D57.411 Sickle-cell thalassemia, unspecified, with acute chest syndrome

Name of the Condition

• Sickle-cell thalassemia, unspecified, with acute chest syndrome

Summary

Sickle-cell thalassemia, unspecified, with acute chest syndrome is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of acute chest syndrome indicates a severe, acute phase with respiratory involvement.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)
• Chest pain, cough, or difficulty breathing (acute chest syndrome)

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin electrophoresis to confirm the specific hemoglobin variant. Chest imaging (e.g., X-ray or CT) may be used to assess respiratory involvement in acute chest syndrome. Additional tests, such as pulse oximetry or arterial blood gas analysis, may evaluate oxygen levels and lung function.

Treatment Options

Treatment focuses on managing acute symptoms and preventing complications. For acute chest syndrome, oxygen therapy, pain management, and antibiotics (if infection is suspected) are common. Blood transfusions may be used to reduce sickle cell levels and improve oxygen delivery. Hydroxyurea or other medications may help reduce crisis frequency. Long-term management includes regular monitoring and preventive care.

Prognosis and Follow-Up

Prognosis depends on the severity of the condition and response to treatment. Acute chest syndrome can be life-threatening but is often manageable with prompt care. Regular follow-up with a hematologist is essential to monitor for complications, adjust treatment, and address ongoing symptoms. Preventive measures, such as vaccinations and avoiding triggers, are critical for reducing crisis episodes.

Complications

• Acute chest syndrome (respiratory distress)
• Stroke or other neurological issues
• Organ damage (e.g., spleen, kidneys, or liver)
• Chronic pain
• Increased risk of infections
• Pulmonary hypertension

Lifestyle & Prevention

• Stay hydrated to reduce blood viscosity
• Avoid extreme temperatures and high altitudes
• Get regular vaccinations (e.g., flu, pneumonia)
• Manage stress and avoid known triggers of crises
• Follow a balanced diet to support overall health
• Engage in moderate exercise as recommended by a healthcare provider

When to Seek Professional Help

Seek immediate medical attention for chest pain, difficulty breathing, severe pain, or signs of infection (e.g., fever, chills). Regular check-ups are important for monitoring the condition and adjusting treatment plans.

Tips for Medical Coders

Document the presence of acute chest syndrome clearly in the medical record, as this is a key component of the code. Ensure the diagnosis aligns with clinical findings, including respiratory symptoms and any supporting tests (e.g., chest imaging). Verify that the unspecified thalassemia type is appropriate if no further subtyping is documented.